Alpine Global Management LLC Purchases 50,000 Shares of Liquidia Co. (NASDAQ:LQDA)

Alpine Global Management LLC increased its holdings in shares of Liquidia Co. (NASDAQ:LQDA - Free Report) by 50.0% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 150,000 shares of the company's stock after buying an additional 50,000 shares during the period. Alpine Global Management LLC owned 0.18% of Liquidia worth $1,764,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the business. Barclays PLC lifted its stake in shares of Liquidia by 265.0% in the 3rd quarter. Barclays PLC now owns 99,984 shares of the company's stock valued at $999,000 after purchasing an additional 72,591 shares during the period. JPMorgan Chase & Co. increased its holdings in Liquidia by 855.3% in the third quarter. JPMorgan Chase & Co. now owns 235,393 shares of the company's stock valued at $2,354,000 after purchasing an additional 210,753 shares during the last quarter. DMC Group LLC lifted its stake in Liquidia by 17.4% in the fourth quarter. DMC Group LLC now owns 16,302 shares of the company's stock valued at $192,000 after buying an additional 2,419 shares during the period. Catalina Capital Group LLC lifted its stake in Liquidia by 6.5% in the fourth quarter. Catalina Capital Group LLC now owns 18,307 shares of the company's stock valued at $215,000 after buying an additional 1,125 shares during the period. Finally, Rhumbline Advisers boosted its holdings in Liquidia by 3.5% during the fourth quarter. Rhumbline Advisers now owns 80,652 shares of the company's stock worth $948,000 after buying an additional 2,741 shares during the last quarter. 64.54% of the stock is currently owned by institutional investors and hedge funds.

Liquidia Price Performance

LQDA traded up $0.09 during trading on Friday, reaching $14.12. The company had a trading volume of 584,669 shares, compared to its average volume of 961,553. The business's fifty day moving average price is $14.40 and its 200 day moving average price is $12.91. Liquidia Co. has a 12 month low of $8.26 and a 12 month high of $16.81. The company has a market cap of $1.20 billion, a P/E ratio of -8.66 and a beta of 0.23.

Liquidia (NASDAQ:LQDA - Get Free Report) last posted its quarterly earnings data on Wednesday, March 19th. The company reported ($0.46) EPS for the quarter, missing the consensus estimate of ($0.38) by ($0.08). Liquidia had a negative net margin of 765.38% and a negative return on equity of 163.21%. The company had revenue of $2.92 million during the quarter, compared to the consensus estimate of $4.60 million. As a group, sell-side analysts predict that Liquidia Co. will post -1.51 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on LQDA. Scotiabank reiterated an "outperform" rating on shares of Liquidia in a research report on Thursday, March 20th. Needham & Company LLC reaffirmed a "buy" rating and issued a $25.00 target price on shares of Liquidia in a research note on Thursday, April 10th. Finally, HC Wainwright reissued a "buy" rating and set a $29.00 price target on shares of Liquidia in a research report on Thursday, March 20th. One investment analyst has rated the stock with a hold rating, six have issued a buy rating and two have assigned a strong buy rating to the company's stock. According to data from MarketBeat, Liquidia currently has a consensus rating of "Buy" and an average price target of $26.63.

Insider Buying and Selling at Liquidia

In other news, insider Rajeev Saggar sold 2,450 shares of Liquidia stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $13.67, for a total value of $33,491.50. Following the sale, the insider now directly owns 263,152 shares in the company, valued at $3,597,287.84. This trade represents a 0.92 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, General Counsel Russell Schundler sold 5,964 shares of the stock in a transaction on Monday, April 14th. The stock was sold at an average price of $13.57, for a total transaction of $80,931.48. Following the transaction, the general counsel now owns 570,301 shares of the company's stock, valued at $7,738,984.57. The trade was a 1.03 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 33,128 shares of company stock worth $450,072. Corporate insiders own 30.10% of the company's stock.

Liquidia Profile

Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).